Together, we conclude that although hepatic RIG-I expression is increased in the first step steatosis stage to promote cholesterol synthesis and lipid accumulation, its expression is decreased in the following NASH and NASH-induced HCC, which may contribute to the inflammation-driven hepatocarcinogenesis. This evidence concerns the gene RIGI and metabolic dysfunction-associated steatohepatitis.